Analyst Report: COHR
1. EXECUTIVE SUMMARY
Coherent closed at $250.60 on Thursday 15 October, down 17.12% from $302.35 a week earlier, in a sector-wide selloff of optical suppliers that 24/7 Wall St. says had no company announcement behind it. The brief points to worries about how AI buildouts will be financed: comments from the Broadcom and Intel chief executives on access to capital and borrowing costs, followed by a rates move and a rotation into defensive sectors, according to 24/7 Wall St. The S&P 500 fell 0.27% over the same period, so the decline sits in the optics group. The latest quarter beat estimates and management describes fiscal 2027 as essentially fully booked, so the reported operating picture has not changed during the week. The next test is fiscal first-quarter earnings on 4 November.
2. THE CATALYST
The brief identifies no Coherent press release in the week (24/7 Wall St., 15 October). The decline came in stages.
| Session | Close | Change | Driver per brief |
|---|---|---|---|
| Thu 8 Oct | $302.35 | -9.63% | Profit-taking in optical names after a year of large gains, hitting the biggest winners hardest (24/7 Wall St.) |
| Fri 9 Oct | $312.62 | +3.40% | Rebound. A TIKR headline blamed rising yields for optics weakness; only the title was seen, so this is unverified |
| Mon 12 Oct | $288.02 | -7.87% | AI funding fears: Broadcom CEO Hock Tan said access to capital could constrain AI expansion more than chip shortages, and Intel CEO Lip-Bu Tan cited higher borrowing costs and uncertain returns on AI spending (24/7 Wall St.; Stocktwits) |
| Tue 13 Oct | $289.98 | +0.68% | No separate driver in the brief |
| Wed 14 Oct | $263.32 | -9.19% | Funding theme continued; 24/7 Wall St. says a hot inflation report lifted the 30-year Treasury yield to 5.63% (single source) |
| Thu 15 Oct | $250.60 | -4.83% | Rotation from AI and technology into defensive sectors (24/7 Wall St.); The Stock Observer ties inflation worries to restrictive rates for richly valued growth shares |
The 12 October and 14 October sessions carried the largest declines inside the measured week. The 15 October session closed on volume of 9,917,100 shares, 1.41 times the 50-session average.
Analyst actions fell in the same days. B. Riley (Dave Kang) kept a Neutral rating and cut its target from $345 to $297, dated 13 October by GuruFocus, while a rallies.ai feed dates the cut to 15 October. Rosenblatt (Mike Genovese) reiterated Buy with a $500 target on 13 October (GuruFocus). Argus lowered its target to $348 (Yahoo Finance Canada, 14 October), with the prior target and rating not available. Bernstein's initiation at Outperform with a $350 target is undated in StockAnalysis.
3. COMPANY PROFILE
Coherent Corp. (Technology, Scientific & Technical Instruments) makes lasers, transceivers, optical and optoelectronic devices, modules and systems. Its Datacenter and Communications segment sells transceivers, co-packaged optics and optical circuit switches. The brief names Lumentum, Fabrinet and Applied Optoelectronics among the companies trading alongside it. Market capitalisation is $49.35bn.
Per 24/7 Wall St. (15 October), the latest quarter delivered non-GAAP EPS of $1.74 against $1.6171 expected, with revenue up 33.7%, the fourth consecutive EPS beat. The CEO said fiscal 2027 is essentially completely booked, with orders extending into calendar 2028. Guidance for the current quarter is revenue of $2.20B to $2.40B and EPS of $1.85 to $2.05, and management targets a first quarter above $3 billion in revenue by the end of fiscal 2027. Indium phosphide output is set to double this quarter, one quarter ahead of plan, co-packaged optics revenue starts ramping in fiscal Q2, and the gross margin target stays above 42%. Nvidia invested $2B in the company (24/7 Wall St.; Stocktwits).
The same 24/7 article reports fiscal 2026 capital spending of $1.103B against operating cash flow of $79.5M, with long-term debt of about $3.2B. This rests on a single source.
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The brief contains no negative company-specific news. Orders, guidance and the capacity ramp all read as before, and the stock now trades at a forward P/E of 17.8 against a trailing 70.4, which shows how much earnings growth the market projects. The reported capex and cash flow figures are the one item in the brief that gives a funding-worried investor something concrete to focus on, since heavy investment is running well ahead of operating cash generation. This link is inference. The brief does not say any investor cited those figures.
Peers. Over the same period Corning fell 9.42% and Amphenol 4.49%, both less than Coherent's 17.12%. 24/7 Wall St. reports Fabrinet and Lumentum sold off alongside Coherent, and that the Roundhill Photonics & Optics ETF, whose two largest holdings are Lumentum and Coherent, fell sharply on 14 October while the S&P 500 was only slightly lower. Applied Optoelectronics was the hardest-hit peer that day without company news; its at-the-market equity programme finished on 5 October, just before the funding warnings, and ten customers made up 99% of its second-quarter revenue.
Comparable episodes. 24/7 Wall St. headlines describe a similar AI optics profit-taking episode on 18 May in which Applied Optoelectronics, Lumentum and Coherent all fell (headline only). The same source also cites an undated instance in which a fiber maker's $2B at-the-market equity offering pushed Coherent 11% lower in sympathy. Both point to a stock that moves with its group on financing news.
Bull case. Orders are booked into 2028, Lumentum's CEO says its optical products are sold out through early 2029 (Stocktwits, undated), and Nvidia holds a $2B stake. The consensus target of $412.52 across 24 analysts (StockAnalysis, undated) sits well above the $250.60 close, as does Rosenblatt's $500. Earnings estimates for 4 November (EPS $1.96, revenue $2.30bn) sit near the middle of guidance, and the company has beaten EPS four times running.
Bear case. The stock has fallen below its 50-day and 200-day averages and is well under its 52-week high of $440.00. The funding argument applies to customers who finance AI buildouts, and the bond market is cited as tightening. Target cuts from B. Riley and Argus arrived during the slide, and B. Riley's $297 target keeps a Neutral rating. Debt of about $3.2B and capital spending far above operating cash flow leave the company exposed to financing costs of its own. The Oct 15 "rotation into defensives" explanation comes from 24/7 Wall St. alone.
5. TECHNICAL SNAPSHOT
The $250.60 close is below both the 50-day average of $301.87 and the 200-day average of $294.28, and it is far under the 52-week high of $440.00 set on 3 June, though still well above the 52-week low of $108.19. It is also the lowest close in the recent table, so no nearby support level exists in the data. The nearest resistance is the 14 October close of $263.32. Thursday's range ran from $235.55 to $252.28, and the close near the top of that range came after an open of $249.84. Volume of 9,917,100 was the heaviest in the table, ahead of 9,285,100 on 8 October.
6. RISK FACTORS
- Funding and rates: further comments on AI financing costs, or a higher long-bond yield, would hit capital-hungry suppliers again. The 5.63% 30-year yield figure rests on one source.
- Group contagion: financing events at other optics companies have pulled Coherent lower in sympathy before, and the sector trades as a bloc.
- Cash generation: capital spending of $1.103B against $79.5M of operating cash flow (single source) and about $3.2B of long-term debt.
- Customer concentration and sentiment: the sector has run far, which leaves it open to profit-taking such as that of 8 October and 18 May.
- Dated catalyst: fiscal 2027 first-quarter results on 4 November, with the discussion at 4:30 p.m. ET (Stock Titan, 14 October). The estimates are EPS of $1.96 and revenue of $2.30bn.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks): Price action depends on rates and AI financing headlines rather than company news, since the brief shows none. The $263.32 level is the first resistance, and the volume on the last session shows heavy participation near the lows. The brief gives no scheduled company event before 4 November.
Medium term (1-3 months): The 4 November report decides the direction. A quarter in line with the $2.30bn revenue estimate, with bookings, margins above 42% and the indium phosphide ramp confirmed, would address the strongest part of the bull case. A miss, softer guidance or a larger funding burden would reinforce the bear case. Analyst targets from $297 to $500 show how wide the range of views is.
Long-term thesis: The brief contains no evidence that the thesis has changed: bookings, capacity expansion and the Nvidia stake are all reported as intact. The valuation question has shifted toward funding conditions, and that is the item to monitor. This is analysis only, not personal financial advice.